Loading clinical trials...
Loading clinical trials...
Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine
Conditions
Interventions
Nicotine transdermal patch
PET Scan with [18F] VAT
Locations
1
United States
Stony Brook University: Dept of Psychiatry
Stony Brook, New York, United States
Start Date
October 3, 2024
Primary Completion Date
September 30, 2029
Completion Date
September 30, 2029
Last Updated
July 31, 2025
NCT07523048
NCT07226661
NCT06793397
NCT07025720
NCT06804525
NCT07462013
Lead Sponsor
Stony Brook University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions